News Quantified

MTNB – matinas biopharma holdings, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Matinas BioPharma to Webcast Conference Call to Discuss First Quarter 2024 Financial Results and Provide a Business Update on May 9, 2024

In Vivo Efficacy of Matinas BioPharma's Oral MAT2203 in Pulmonary Mucormycosis Published in Journal of Antimicrobial Agents and Chemotherapy [Yahoo! Finance]

Lundquist Investigator Dr. Ashraf Ibrahim Is the Lead Author in the Landmark Study on Pioneering Oral Fungal Infection Treatment Showing Promise in Preclinical Trials [Yahoo! Finance]

In Vivo Efficacy of Matinas BioPharma’s Oral MAT2203 in Pulmonary Mucormycosis Published in Journal of Antimicrobial Agents and Chemotherapy

Matinas BioPharma Prices $10 Million Registered Direct Offering [Yahoo! Finance]

-28.7%

IN-LINE

Form 8-K Matinas BioPharma Holdin For: Apr 02

Form 424B5 Matinas BioPharma Holdin

Form 8-K Matinas BioPharma Holdin For: Mar 28

Form 8-K Matinas BioPharma Holdin For: Mar 27

Form 10-K Matinas BioPharma Holdin For: Dec 31

Top News Gainers

11/18 Matinas BioPharma to Present at the 31st Annual Piper Jaffray Healthcare Conference 14.8%

7/30 Matinas BioPharma to Webcast Conference Call Discussing Second Quarter 2019 Operational and Financial Results on August 13, 2019 8.8%

8/13 Q2/2019 6/30/2019 EPS -0.030 ZacksConsensus -0.040 ActVsEst 0.010 - Beat 7.8%

11/14 Matinas BioPharma Holdings, Inc. (MTNB) CEO Jerry Jabbour on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 7.8%

4/8 Form 4 Matinas BioPharma Holdin For: Apr 03 Filed by: STERN ADAM K 7.5%

5/13 Form 10-Q Matinas BioPharma Holdin For: Mar 31 5.4%

6/3 Form 4 Matinas BioPharma Holdin For: May 31 Filed by: STERN ADAM K 4.9%

2/2 5 Stocks Under $5 With Colossal Growth Prospects [Yahoo! Finance News] 4.4%

11/28 Edited Transcript of MTNB earnings conference call or presentation 13-Nov-19 1:00pm GMT [Yahoo! Finance News] 4.2%

3/9 Matinas BioPharma Holdings, Inc. (MTNB) CEO Jerry Jabbour on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] 3.8%

Top News Decliners

7/25 Matinas BioPharma Receives Qualified Infectious Disease Product (QIDP) and Fast Track Designations From U.S. FDA for MAT2203 for the Treatment of Cryptococcal Meningitis -14.0%

1/9 Form 424B5 Matinas BioPharma Holdin -13.1%

3/9 Q4/2019 12/31/2019 EPS -0.040 ZacksConsensus -0.030 ActVsEst (0.010) - Miss -13.0%

1/10 Form 8-K Matinas BioPharma Holdin For: Jan 09 -10.3%

1/7 Here's Why Matinas BioPharma Shares Lost as Much as 16.9% Today [The Motley Fool] -9.4%

3/31 Matinas BioPharma Provides Comment on Impact of Vascepa® Patent Litigation on MAT9001 and Update on COVID-19 Pandemic’s Effect on Business Operations and Clinical Programs -9.0%

4/2 Form 4 Matinas BioPharma Holdin For: Mar 31 Filed by: WIKLER MATTHEW -7.5%

3/18 Form 4 Matinas BioPharma Holdin For: Mar 17 Filed by: STERN ADAM K -7.4%

5/28 Matinas BioPharma Announces Publication of MAT2203 Preclinical Cryptococcal Meningitis Data in the American Society for Microbiology Journal, mBio -6.8%

1/3 Form 4 Matinas BioPharma Holdin For: Jan 01 Filed by: MANNINO RAPHAEL J -6.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day